Going Concern (Details Narrative) (USD $)	3 Months Ended	107 Months Ended
	Jun. 30, 2014	Jun. 30, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Non-cash gain upon deconsolidation ofEntest Biomedical, Inc.		$ 41,645,688
Net Losses		18,136,615
Equity in Net Losses of Entest Biomedical, Inc.		663,649
Net borrowings from CEO	$ 12,094